{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:06:32Z","timestamp":1787065592653,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Key R&D Program of China","award":["2017YFA0505600 and 2016YFA0502100"],"award-info":[{"award-number":["2017YFA0505600 and 2016YFA0502100"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81602364, 81621004, 81520108022, 81572403"],"award-info":[{"award-number":["81602364, 81621004, 81520108022, 81572403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2014B020210002 and 2017A020211010"],"award-info":[{"award-number":["2014B020210002 and 2017A020211010"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012241","name":"Guangzhou Research Collaborative Innovation Projects","doi-asserted-by":"crossref","award":["201400000001 and 20150802024"],"award-info":[{"award-number":["201400000001 and 20150802024"]}],"id":[{"id":"10.13039\/501100012241","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Sci-Tech Project Foundation of Guangzhou City","award":["201607020038"],"award-info":[{"award-number":["201607020038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00109-020-01963-2","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:21:19Z","timestamp":1598314879000},"page":"1457-1466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer"],"prefix":"10.1007","volume":"98","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Chong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Sheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-291X","authenticated-orcid":false,"given":"Guo-Kai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"issue":"1","key":"1963_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40880-016-0137-8","volume":"35","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Zeng H, Zhang S (2016) The incidence and mortality of major cancers in China, 2012. Chin J Cancer 35(1):73","journal-title":"Chin J Cancer"},{"issue":"2","key":"1963_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.soc.2017.11.003","volume":"27","author":"S Shawki","year":"2018","unstructured":"Shawki S, Ashburn J, Signs SA, Huang E (2018) Colon cancer: inflammation-associated cancer. Surg Oncol Clin N Am 27(2):269\u2013287","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"1963_CR3","first-page":"303","volume":"49","author":"AM Cimpean","year":"2008","unstructured":"Cimpean AM, Raica M, Suciu C, Tatucu D, Sarb S, Muresan AM (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. Romanian J Morphol Embryol 49(3):303\u2013308","journal-title":"Romanian J Morphol Embryol"},{"key":"1963_CR4","doi-asserted-by":"publisher","first-page":"6027305","DOI":"10.1155\/2017\/6027305","volume":"2017","author":"R Singh","year":"2017","unstructured":"Singh R, Mishra MK, Aggarwal H (2017) Inflammation, immunity, and cancer. Mediat Inflamm 2017:6027305","journal-title":"Mediat Inflamm"},{"issue":"7203","key":"1963_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444","journal-title":"Nature"},{"issue":"1","key":"1963_CR6","first-page":"679","volume":"16","author":"S Zhang","year":"2018","unstructured":"Zhang S, Yang X, Wang L, Zhang C (2018) Interplay between inflammatory tumor microenvironment and cancer stem cells. Oncol Lett 16(1):679\u2013686","journal-title":"Oncol Lett"},{"issue":"5","key":"1963_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1200\/JCO.2005.12.172","volume":"23","author":"JJ Chen","year":"2005","unstructured":"Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC (2005) Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23(5):953\u2013964","journal-title":"J Clin Oncol"},{"issue":"6","key":"1963_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neo.2015.05.002","volume":"17","author":"C Lindemann","year":"2015","unstructured":"Lindemann C, Marschall V, Weigert A, Klingebiel T, Fulda S (2015) Smac mimetic-induced upregulation of CCL2\/MCP-1 triggers migration and invasion of glioblastoma cells and influences the tumor microenvironment in a paracrine manner. Neoplasia 17(6):481\u2013489","journal-title":"Neoplasia"},{"issue":"46","key":"1963_CR9","doi-asserted-by":"publisher","first-page":"80235","DOI":"10.18632\/oncotarget.10288","volume":"8","author":"J Bayo","year":"2017","unstructured":"Bayo J, Real A, Fiore EJ, Malvicini M, Sganga L, Bolontrade M, Andriani O, Bizama C, Fresno C, Podhajcer O, Fernandez E, Gidekel M, Mazzolini GD, Garc\u00eda MG (2017) IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness. Oncotarget 8(46):80235\u201380248","journal-title":"Oncotarget"},{"key":"1963_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cellimm.2018.07.012","volume":"331","author":"C Bleriot","year":"2018","unstructured":"Bleriot C, Ginhoux F (2018) Macrophage depletion in cancer therapy: a double-edged sword. Cell Immunol 331:178\u2013179","journal-title":"Cell Immunol"},{"key":"1963_CR11","doi-asserted-by":"crossref","unstructured":"Watanabe R, Hilhorst M, Zhang H, Zeisbrich M, Berry GJ, Wallis BB, Harrison DG, Giacomini JC, Goronzy JJ, Weyand CM (2018) Glucose metabolism controls disease-specific signatures of macrophage effector functions. JCI Insight 3(20):e123047","DOI":"10.1172\/jci.insight.123047"},{"issue":"41","key":"1963_CR12","doi-asserted-by":"publisher","first-page":"16386","DOI":"10.1021\/ja2070889","volume":"133","author":"CL Strelko","year":"2011","unstructured":"Strelko CL, Lu W, Dufort FJ, Seyfried TN, Chiles TC, Rabinowitz JD, Roberts MF (2011) Itaconic acid is a mammalian metabolite induced during macrophage activation. J Am Chem Soc 133(41):16386\u201316389","journal-title":"J Am Chem Soc"},{"issue":"1","key":"1963_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/jir.2008.0013","volume":"29","author":"D Degrandi","year":"2009","unstructured":"Degrandi D, Hoffmann R, Beuter-Gunia C, Pfeffer K (2009) The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. J Interf Cytokine Res 29(1):55\u201367","journal-title":"J Interf Cytokine Res"},{"issue":"1","key":"1963_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, Cervantes-Barragan L, Ma X, Huang SC, Griss T et al (2016) Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab 24(1):158\u2013166","journal-title":"Cell Metab"},{"issue":"3","key":"1963_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2016.08.013","volume":"24","author":"HH Luan","year":"2016","unstructured":"Luan HH, Medzhitov R (2016) Food fight: role of itaconate and other metabolites in antimicrobial defense. Cell Metab 24(3):379\u2013387","journal-title":"Cell Metab"},{"issue":"7699","key":"1963_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, Szpyt J, Runtsch MC, King MS, McGouran JF, Fischer R, Kessler BM, McGettrick AF, Hughes MM, Carroll RG, Booty LM, Knatko EV, Meakin PJ, Ashford MLJ, Modis LK, Brunori G, S\u00e9vin DC, Fallon PG, Caldwell ST, Kunji ERS, Chouchani ET, Frezza C, Dinkova-Kostova AT, Hartley RC, Murphy MP, O\u2019Neill LA (2018) Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556(7699):113\u2013117","journal-title":"Nature"},{"issue":"10","key":"1963_CR17","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1136\/gutjnl-2017-314241","volume":"67","author":"RR Gerner","year":"2018","unstructured":"Gerner RR, Klepsch V, Macheiner S, Arnhard K, Adolph TE, Grander C, Wieser V, Pfister A, Moser P, Hermann-Kleiter N, Baier G, Oberacher H, Tilg H, Moschen AR (2018) NAD metabolism fuels human and mouse intestinal inflammation. Gut 67(10):1813\u20131823","journal-title":"Gut"},{"issue":"8","key":"1963_CR18","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/ijc.31191","volume":"142","author":"AL Ray","year":"2018","unstructured":"Ray AL, Berggren KL, Restrepo Cruz S, Gan GN, Beswick EJ (2018) Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha-dependent colorectal cancer growth. Int J Cancer 142(8):1702\u20131711","journal-title":"Int J Cancer"},{"issue":"8","key":"1963_CR19","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/nprot.2007.279","volume":"2","author":"C Neufert","year":"2007","unstructured":"Neufert C, Becker C, Neurath MF (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2(8):1998\u20132004","journal-title":"Nat Protoc"},{"issue":"5","key":"1963_CR20","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1002\/jcp.27425","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Goradel NH, Farhood B, Salehi E, Solhjoo S, Toolee H, Kharazinejad E, Mortezaee K (2019) Tumor microenvironment: Interactions and therapy. J Cell Physiol 234(5):5700\u20135721","journal-title":"J Cell Physiol"},{"issue":"4","key":"1963_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.1001232","volume":"4","author":"L Danelli","year":"2015","unstructured":"Danelli L, Frossi B, Pucillo CE (2015) Mast cell\/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology 4(4):e1001232","journal-title":"Oncoimmunology"},{"issue":"2","key":"1963_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1566523219666190618093707","volume":"19","author":"T Yang","year":"2019","unstructured":"Yang T, Li J, Li R, Yang C, Zhang W, Qiu Y, Yang C, Rong R (2019) Correlation between MDSC and immune tolerance in transplantation: cytokines, pathways and cell-cell interaction. Curr Gene Ther 19(2):81\u201392","journal-title":"Curr Gene Ther"},{"issue":"2","key":"1963_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152(2):313\u2013321 e312","journal-title":"Gastroenterology"},{"issue":"1","key":"1963_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/mc.22484","volume":"56","author":"H Kim","year":"2017","unstructured":"Kim H, Banerjee N, Barnes RC, Pfent CM, Talcott ST, Dashwood RH, Mertens-Talcott SU (2017) Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126\/PI3K\/AKT\/mTOR axis in vitro and in vivo. Mol Carcinog 56(1):197\u2013207","journal-title":"Mol Carcinog"},{"issue":"2","key":"1963_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","volume":"15","author":"S Grivennikov","year":"2009","unstructured":"Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, Karin M (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15(2):103\u2013113","journal-title":"Cancer Cell"},{"issue":"12","key":"1963_CR26","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/embor.2009.243","volume":"10","author":"J Bollrath","year":"2009","unstructured":"Bollrath J, Greten FR (2009) IKK\/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10(12):1314\u20131319","journal-title":"EMBO Rep"},{"issue":"3","key":"1963_CR27","first-page":"187","volume":"45","author":"M Abdullah","year":"2013","unstructured":"Abdullah M, Rani AA, Sudoyo AW, Makmun D, Handjari DR, Hernowo BS (2013) Expression of NF-kB and COX2 in colorectal cancer among native Indonesians: the role of inflammation in colorectal carcinogenesis. Acta Med Indonesiana 45(3):187\u2013192","journal-title":"Acta Med Indonesiana"},{"issue":"12","key":"1963_CR28","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","volume":"23","author":"J Kim","year":"2005","unstructured":"Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS (2005) Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23(12):2744\u20132753","journal-title":"J Clin Oncol"},{"issue":"5","key":"1963_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/01.mpg.0000221896.45910.9a","volume":"42","author":"AK Akobeng","year":"2006","unstructured":"Akobeng AK (2006) Infliximab for induction and maintenance therapy for ulcerative colitis. J Pediatr Gastroenterol Nutr 42(5):589\u2013590","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1963_CR30","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/j.gastro.2006.09.039","volume":"131","author":"AC Moss","year":"2006","unstructured":"Moss AC, Farrell RJ (2006) Infliximab for induction and maintenance therapy for ulcerative colitis. Gastroenterology 131(5):1649\u20131651 discussion 1651","journal-title":"Gastroenterology"},{"issue":"3","key":"1963_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","volume":"132","author":"J Hyams","year":"2007","unstructured":"Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R, REACH Study Group (2007) Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 132(3):863\u2013873 quiz 1165-1166","journal-title":"Gastroenterology"},{"issue":"12","key":"1963_CR32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/gut.2009.203000","volume":"59","author":"FV Din","year":"2010","unstructured":"Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59(12):1670\u20131679","journal-title":"Gut"},{"issue":"1","key":"1963_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/annonc\/mdu225","volume":"26","author":"J Cuzick","year":"2015","unstructured":"Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ, Jankowski JA, La Vecchia C et al (2015) Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol 26(1):47\u201357","journal-title":"Ann Oncol"},{"issue":"1","key":"1963_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/med.21514","volume":"39","author":"H Hua","year":"2019","unstructured":"Hua H, Zhang H, Kong Q, Wang J, Jiang Y (2019) Complex roles of the old drug aspirin in cancer chemoprevention and therapy. Med Res Rev 39(1):114\u2013145","journal-title":"Med Res Rev"},{"issue":"4","key":"1963_CR35","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","volume":"116","author":"I Kaplanov","year":"2019","unstructured":"Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin GV, Shurin MR, Dinarello CA, Voronov E, Apte RN (2019) Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A 116(4):1361\u20131369","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"1963_CR36","doi-asserted-by":"publisher","first-page":"75571","DOI":"10.18632\/oncotarget.12289","volume":"7","author":"I Holen","year":"2016","unstructured":"Holen I, Lefley DV, Francis SE, Rennicks S, Bradbury S, Coleman RE, Ottewell P (2016) IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget 7(46):75571\u201375584","journal-title":"Oncotarget"},{"key":"1963_CR37","doi-asserted-by":"publisher","first-page":"36107","DOI":"10.1038\/srep36107","volume":"6","author":"B Guo","year":"2016","unstructured":"Guo B, Fu S, Zhang J, Liu B, Li Z (2016) Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Sci Rep 6:36107","journal-title":"Sci Rep"},{"issue":"12","key":"1963_CR38","first-page":"2134","volume":"54","author":"G Cavalli","year":"2015","unstructured":"Cavalli G, Dinarello CA (2015) Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford) 54(12):2134\u20132144","journal-title":"Rheumatology (Oxford)"},{"issue":"10105","key":"1963_CR39","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ, Group CT (2017) Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390(10105):1833\u20131842","journal-title":"Lancet"},{"issue":"Suppl 26","key":"1963_CR40","doi-asserted-by":"publisher","first-page":"S3084","DOI":"10.21037\/jtd.2018.07.50","volume":"10","author":"D Crossman","year":"2018","unstructured":"Crossman D, Rothman AMK (2018) Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS). J Thorac Dis 10(Suppl 26):S3084\u2013S3087","journal-title":"J Thorac Dis"},{"issue":"5","key":"1963_CR41","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1021\/pr101054m","volume":"10","author":"JH Shin","year":"2011","unstructured":"Shin JH, Yang JY, Jeon BY, Yoon YJ, Cho SN, Kang YH, Ryu DH (2011) Hwang GS: (1)H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res 10(5):2238\u20132247","journal-title":"J Proteome Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01963-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T19:10:20Z","timestamp":1629832220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01963-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1963"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01963-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"10 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) in Sun Yat-sen University Cancer Center (IACUC approval number L102012016060F).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}